Allianz Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Allianz Asset Management's VCYT Position: Q2 2026 in Review
Allianz Asset Management reduced its Veracyte (VCYT) stake by 16% in Q2 2026, selling an estimated $1.04M and leaving 134,150 shares worth $7.88M. The position accounts for 0.01% of the portfolio, ranked #1190.
Allianz Asset Management first reported a position in VCYT in Q2 2018 and has held it in 20 quarters since. The position peaked at $14.5M in Q1 2019. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Allianz Asset Management held 134,150 shares of Veracyte worth $7.88M as of Q2 2026.
- Allianz Asset Management sold 24,721 Veracyte shares in Q2 2026, an estimated $1.04M.
- Veracyte made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1190 holding.
- Allianz Asset Management first reported a position in Veracyte in Q2 2018 and has held it in 20 quarters since.
- Allianz Asset Management's Veracyte position peaked at $14.5M in Q1 2019.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.